Tezspire 210 MG/1.91 ML syring 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FBFSE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,154
Award facts
- Contract value 100% obligated
- $35,153.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,153.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 mL syringes. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This contract is a child order under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026.
Tezspire is a specialty biologic medication used in the treatment of severe eosinophilic asthma and other allergic conditions. This delivery order reflects AmerisourceBergen Drug Corp's role as a critical pharmaceutical supplier for federal military and veteran healthcare systems. The award demonstrates the company's capability to supply specialized medications and medical devices through competitive procurement channels to support the Defense Health Agency and other military medical supply chain operations. The SPE2DX vehicle under which this order falls serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen Drug Corp to distribute a wide range of brand-name and generic pharmaceuticals, vaccines, and related medical supplies to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FBFSE?
SPE2DB25FBFSE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FBFSE worth?
The government has obligated $35,154 on SPE2DB25FBFSE.
Is contract SPE2DB25FBFSE an order under another contract?
Yes. SPE2DB25FBFSE is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBFSE competed?
The extent of competition for SPE2DB25FBFSE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award